How do I tell if its benign PVCs or ARVC? Robert M. Hamilton The - - PowerPoint PPT Presentation

how do i tell if it s benign pvc s or arvc
SMART_READER_LITE
LIVE PREVIEW

How do I tell if its benign PVCs or ARVC? Robert M. Hamilton The - - PowerPoint PPT Presentation

How do I tell if its benign PVCs or ARVC? Robert M. Hamilton The Hospital for Sick Children & Research Institute Autopsy from Ten Year Old Female following Sudden Cardiac Death Why differentiate RVOT VT/PVCs from A(RV)C? }


slide-1
SLIDE 1

How do I tell if it’s benign PVC’s

  • r ARVC?

Robert M. Hamilton The Hospital for Sick Children & Research Institute

slide-2
SLIDE 2

 Autopsy from Ten

Year Old Female following Sudden Cardiac Death

slide-3
SLIDE 3

Why differentiate RVOT VT/PVC’s from A(RV)C?

 RVOT VT is relatively benign  ARVC is a progressive disease and a

significant cause of sudden cardiac death.

 Even in Children!

Tabib, 2003 DuPuis, 2005 Pilmer, 2014

}

25%

slide-4
SLIDE 4

Right Ventricular Outflow Tract VT(PVC’s)

 Monomorphic VT originating from RVOT  Usually no underlying structural heart disease  May also occur in the context of ARVC

Heart rate > 100 bpm. QRS duration > 120 ms. LBBB Morphology Rightward / inferior axis (around +90 degree) ±VA dissociation.

slide-5
SLIDE 5

Right Ventricular Outflow Tract VT

 Two predominant forms (Lerman et al, 1996)

repetitive monomorphic nonsustaincd VT paroxysmal exercise induced sustained VT

slide-6
SLIDE 6
slide-7
SLIDE 7

 48 Children with RVOT VT (5 Centers)

 8.2 yrs (0.1-17.0 yrs); F/U 22 mo. (1-210

mo.)

82% referred for incidental finding, but 46%

reported symptoms to cardiologist

15% referred for syncope or near-syncope 40% had a history of exercise intolerance 10% had a family history of arrhythmia

slide-8
SLIDE 8

 MRI performed in 25 (52%)

abnormalities in 13 (wall thinning in 8, fatty

infiltration in 4, fibrosis in 2, and dyskinesia in 2)

 Biopsies performed in 12 (25%)

Minor changes in 5 (fibrosis, interstitial lymphocyte

infiltration, interstitial edema, and mild hypertrophy)

 Catheterization performed in 11 (23%)

findings included focal dyskinesia in 1, apical

hypokinesia in 1 & segmental wall-motion abn. in 1 Some may have had early ARVC, but no deaths occurred

slide-9
SLIDE 9

 Derivation Cohort: 16 ARVD/C v. 42 RVOT-VT  Validation Cohort: 37 ARVD/C v. 49 RVOT-VT  ARVD/C met task force criteria  RVOT-VT Structurally Nl, Successfully Ablated

slide-10
SLIDE 10

 No difference in Sx or Exercise-related Sx  FH in 60% of ARVC, 0% of RVOTO-VT  Abn ECG in 52% of ARVC. T-inv. In 36%  Abn SAECG in 78% of ARVC, NoRVOTO-VT  All RVOT-VT and 53% of ARVC: inf. axis VT  42% of ARVC had 2+ morphologies of VT  PES ind. VT in ARVC, Isuprel in RVOT-VT  Fragmented Potentials v. Presystolic Potentials

slide-11
SLIDE 11

 Compared LBBB-Inf. Axis Arrhythmias

between ARVC and RVOT-VT

 Follow-up not stated  ARVC had:

Longer mean QRSdd (150±31 v. 123±34 ms) Precordial transition in V6 (3/17 v. 0//42) Notching in 1+ lead (11/17 v. 9/42)

slide-12
SLIDE 12

Differentiating RVOT VT from ARVC

Feature RVOT VT ARVC Mechanism Unifocal LBBB Nl Axis Re-entry (slow conduction) PVC’s Unifocal LBBB Nl Axis Multifocal LBBB VT Repetitive MMVT+/or Paroxysmal Ex.-ind. Stress-related MMVT QRS Normal +/- prolonged S duration in V1 Normal +/- prolonged SAECG Normal +/- prolonged MRI Normal +/- RV dil & dysk T-wave altenans Negative +/- positive Ablation Success in 94%

  • Var. success and recurrence

Family History VT/SCD Negative Often Positive Genetic basis Somatic mutation in Desmosomal in 1/3

slide-13
SLIDE 13

General observations

 Understanding PVC’s is complex. They are

  • capricious. Often can’t find out why they come,

leave, come back.

 Response to exercise helpful but not absolute

(Gross)

 PVC’s are defined by the company they keep

(Usially benign if isolated and heart is structurally and functionally normal)

 Freq. PVC’s or isolated RVOT VT = a single

minor Task Force criterion (ARVC unlikely)

slide-14
SLIDE 14

My Approach

 Take a family history!  Asymptomatic PVC’s

 Assess morphology: RVOT vs. LV vs. RV body  ECG, Holter, SAECG (≥5), Ex. Test (≥6), Echo  Consider 12-lead Holter, ? T-wave alternans  Not RVOT morphology, multiple morphologies or abn

SAECG or Echo: MRI (≥9)

 Minimally symptomatic (palpitations)

 Non-invasive monitors

 Symptomatic (syncope: non-vasodepressor)

 MRI, genetics, ±EP study, ILR  ?ARVC: Genetics, biomarker in development

slide-15
SLIDE 15
slide-16
SLIDE 16

Master Thesis Sarah Vermij (Toon van Veen) June 2014

Q U E S T I O N S ?

robert.hamilton@sickkids.ca